Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Payables (2018 - 2025)

AVITA Medical filings provide 8 years of Payables readings, the most recent being $9.0 million for Q4 2025.

  • On a quarterly basis, Payables rose 42.34% to $9.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.0 million, a 42.34% increase, with the full-year FY2025 number at $9.0 million, up 42.34% from a year prior.
  • Payables hit $9.0 million in Q4 2025 for AVITA Medical, up from $8.1 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $9.0 million in Q4 2025 to a low of $2.4 million in Q1 2022.
  • Median Payables over the past 5 years was $3.8 million (2023), compared with a mean of $4.5 million.
  • Biggest five-year swings in Payables: crashed 34.11% in 2022 and later surged 93.81% in 2025.
  • AVITA Medical's Payables stood at $2.7 million in 2021, then rose by 10.86% to $3.0 million in 2022, then rose by 26.35% to $3.8 million in 2023, then skyrocketed by 65.94% to $6.3 million in 2024, then surged by 42.34% to $9.0 million in 2025.
  • The last three reported values for Payables were $9.0 million (Q4 2025), $8.1 million (Q3 2025), and $7.3 million (Q2 2025) per Business Quant data.